Paul Kearney Email & Phone Number

Salt Lake City, Ut, Us

Oversees Data Science and Data Analytics; product development strategy; evidence development; data narratives; supports commercialization, publication, research and development activities.

Salt Lake City, Ut, Us

Sera Prognostics was founded to develop diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera’s tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans.The company has completed Its landmark Proteomic Assessment of Preterm Risk (PAPR) clinical study that clinically validated the PreTRM test as highly predictive of preterm birth early in pregnancy. To read more about this study, and its subsequent publication, see the link below.The company’s proteomic predictor of premature birth risk -- the PreTRM® Test for Risk Management-became commercially available in the U.S. in early 2016.

Your data tells a story. Data Incites is a consulting group providing world class data science expertise and experience to life science and biotechnology companies. Services include bioinformatics, biostatistics, machine learning, clinical research, data analysis, data visualization, FDA/CLIA/CAP/HIPAA regulatory support, biotechnology product development, companion diagnostics, and biomarker development.

Hatfield, Pennsylvania, Us

The mission of AllerGenis is to develop precision diagnostic solutions that can help providers better screen, assess, and manage the well-being of millions of food allergy patients. Specializing in immunology and bioinformatics, AllerGenis created a highly multiplexed analytical platform to address the limitations of current tests and to provide a better predictor of patient response to future immunotherapy and drug treatments.The company started as a collaboration between Genisphere, a provider of the 3DNA® platform for targeted drug delivery, and Hugh Sampson, MD, of the Elliot and Roslyn Jaffe Food Allergy Institute of the Icahn School of Medicine at Mount Sinai. The solution leverages Genisphere's Luminex bead-based immunoassay technology (used to make life science and diagnostics tests more sensitive) and epitope mapping technology based on immunological research by Dr. Hugh Sampson.

I co-founded Integrated Diagnostics (Indi) in 2009 with Leroy Hood, the founder of the Institute for Systems Biology in Seattle. We sold the company to Biodesix in summer 2018.Indi was a biotechnology company leveraging systems biology concepts and an advanced multiplexed proteomic platform to develop and commercialize high-value diagnostics. I was critical in the conception, funding, development, and commercialization of the first product (Xpresys) for lung cancer management. While there I developed the first multiplexed mass spectrometry platform for a high value diagnostic, along with many associated patents and high profile publications. Then I oversaw the translation of this novel technology into a regulated commercial laboratory providing a test used in the clinic today. However, my most important contribution was the assembly of a top management team of scientists, data analysts, laboratorians and IP experts, among others.

Seattle, Washington, Us

I was hired by Leroy Hood in 2008 to be the Scientific Director of Special Projects with the Institute for Systems Biology. ISB is an international leader in biotechnological innovation, integrating genomic, proteomic, and bioinformatic tools for complex biological systems analysis.I was tasked with the development and completion of a $100M personalized medicine research proposal in collaboration with the University of Luxembourg.

Caprion Proteomics is an internationally recognized leader in proteomics, specializing in biomarker discovery, immunotherapy target discovery, and infectious diseases research. Clients include most major pharmaceutical and biotech companies as well as the NIH.As the Vice President of Bioinformatics with Caprion, I provided vision for all aspects of study design, data analysis, statistics, interpretation, and data visualization. I was also the manager of proteomic platform technology, including the evaluation of new technologies, identification and implementation of process improvements.

Waterloo, Ontario, Ca

Ph.D., Bioinformatics/Computer Science

M.Sc., Computer Science